Improving adenoviral vectors and strategies for prostate cancer gene therapy
Gene therapy has been evaluated for the treatment of prostate cancer and includes the application of adenoviral vectors encoding a suicide gene or oncolytic adenoviruses that may be armed with a functional transgene. In parallel, versions of adenoviral vector expressing the p53 gene (Ad-p53) have be...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Elsevier España
2018-08-01
|
| Saila: | Clinics |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322018000200309&lng=en&tlng=en |